Effects of a Central Cholinesterase Inhibitor on Reducing Falls in Parkinson Disease

Neurology - United States
doi 10.1212/wnl.0b013e3181f6128c
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Effect of a Cholinesterase Inhibitor on the Vitality in Alzheimer Disease

Japanese Journal of Geriatrics
GerontologyGeriatrics
2009English

Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients

Current Alzheimer Research
Neurology
2009English

Practical Tips on Reducing Hazards of Falls.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Effects of Subthalamic Nucleus Stimulation on Motor Cortex Plasticity in Parkinson Disease

Neurology
Neurology
2015English

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

JAMA Neurology
Neurology
2020English

Potentiation of a Functional Autoantibody in Narcolepsy by a Cholinesterase Inhibitor

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2009English

Differential Effects of Severe vs Mild GBA Mutations on Parkinson Disease

Neurology
Neurology
2015English

Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer's Disease

Journal of Managed Care Pharmacy
2008English

Economic Evaluation of a Tai Ji Quan Intervention to Reduce Falls in People With Parkinson Disease, Oregon, 2008–2011

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy